University of Ioannina
Η φυσική ιστορία της χρόνιας ενεργού ηπατίτιδας Β ( HBV), C ( HCV) και D ( HDV) μετά από θεραπεία με ιντερφερόνη Α ( IFN α) στη Β.Δ. Ελλάδα
Abstract
dc:descriptionInterferon-alpha (IFN-a) is a widely applicated therapy of chronic HBV and HCV infection. The aim of the study was to evaluate the effect of interferon-a therapy on the long-term outcome (natural history) of chronic hepatitis B and C in north-western Greece. Patients-Methods: 79 patients [52 male (65.8%) and 27 female (34.2%), mean ± sd=48.70 ± 15.43] with chronic hepatitis B (HBV) and 49 patients [29 male (59.2%) and 20 female (40.8%) mean ± sd=51.18 ± 15.12] with chronic hepatitis C (HCV),who underwent IFN-a therapy (patients with HBV received 4.5 MU three times weekly and those with HCV received 3 MU three times weekly, sc) were followed up for serological status, biochemical evidence of liver disease, and liver complications or mortality through 6 years after start of treatment. Complete responders are defined as patients who had sustained normal ALT levels with clearance of HBV-DNA and HCV-RNA for more than 6 months after cessation of IFN-a therapy. Patients with decompensated liver disease and/or hepatocellular carcinoma at presentation were excluded. Pretreatment liver biopsies were performed and all patients had histological evidence of chronic hepatitis B and C. A lot of patients underwent a second liver biopsy. Liver biopsy histology was graded using the histology activity index (HAI). Results: The biochemical and virological responses for the patients with chronic active hepatitis B, at the end of treatment were 30% and 44% (for 6 and the 12 months regimen, respectively), (p=0.05). At the end of 6 -12 months after stop of therapy biochemical and virological sustained response was observed in 35% and 32%. Histological improvement of activity observed in patients with sustained virological response (p<0.001). Overall survival and survival without clinical complications were significantly longer in patients who were sustained virological response after therapy with IFN-a than in those who observed without sustained virological response (p=0.002). The biochemical and virological responses for the patients with chronic active hepatitis C, at the end of treatment were 31 % and 71 % (for 6 and the12 months regimen, respectively), (p=0.005). At the end of 6 -12 months after stop of therapy biochemical and virological sustained response was observed in 69% and 59%. Histological improvement of activity observed in patients with sustained virological response (p=0.04). Overall survival and survival without clinical complications were significantly longer in patients who were sustained virological response after therapy with IFN-a than in those who observed without sustained virological response (p=0.0000). Conclusions: In patients with chronic active hepatitis B and C (HBV and HCV), sustained biochemical remission induced by interferon-a is associated with improved long-term outcome. The results suggest that IFN-a has long-term beneficial effects in histological improvement, reduction of HCC, and prolonging survival.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Baltagiannis, Gerasimos
- Μπαλταγιάννης, Γεράσιμος
Subjects
dc:subject × 20- Χρόνια ενεργός ηπατίτιδα B, C, D
- Ιντερφερόνη-α
- Κίρρωση ήπατος
- Επιβίωση
- Ιστολογική βελτίωση
- Ιολογική απόκριση
- Βιοχημική ανταπόκριση
- Παρατεταμένη ανταπόκριση
- Chronic active hepatitis B, C, D
- Interferon-α
- Cirrhosis
- Survival improvement
- Histological improvement
- Virologic improvement
- Biochemical improvement
- Sustained response
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21809